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Bacteria in biofilms are much more resistant to antibiotics and microbicides compared 
to their planktonic stage. Thus, to achieve the same antibacterial efficacy, a much 
higher dose of antibiotics is required for biofilm bacteria. However, the widespread 
use of antibiotics has been recognized as the main cause for the emergence of 
antibiotic-resistant microbial species, which has now become a major public health 
crisis globally. In this work, we present an efficient non-antibiotic-based strategy for 
disrupting biofilms using carboxymethyl chitosan (CMCS) coated on magnetic iron 
oxide nanoparticles (CMCS-MNPs). CMCS-MNPs demonstrate strong bactericidal 
activities against both Gram-positive Staphylococcus aureus (S. aureus) and 
Gram-negative Escherichia coli (E. coli) planktonic cells. More than 99% S. aureus 
and E. coli planktonic cells were killed after incubation with CMCS-MNPs for 10 h 
and 5 h, respectively. In the presence of a magnetic field (MF), CMCS-MNPs can 
effectively penetrate into both S. aureus and E. coli biofilms, resulting in a reduction 
of viable cells counts by 84% and 95%, respectively, after 48 h incubation, compared 
to the control experiment without CMCS-MNPs or CMCS. CMCS-MNPs are 
non-cytotoxic towards mammalian cells and can potentially be a useful antimicrobial 
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Bacteria growing in biofilms are embedded within a self-produced matrix of 
extracelluar polymeric substance (EPS), and thus can be insensitive to antibiotics and 
microbicides that could eliminate them in the plankonic state (Branda et al., 2005, 
Ramage et al., 2010). In general, biofilm cells are 100- to 1000-fold more resistant to 
antibiotic treatment. The resistance mechanisms are associated with the morphology 
of the biofilms, whereby the EPS matrix of biofilms can present a generic barrier to 
the diffusion of antibiotics. Measurements of antibiotics penetration into biofilms 
have shown that some antibiotics cannot readily permeate biofilms (Stewart et al., 
1996). Furthermore, the exchange of genetic materials and the mutation of bacteria in 
biofilms occur more frequently than in planktonic populations. Therefore, 
development of resistance mechanisms can quickly be selected for and propagated 
throughout the community. In addition, the cells in the deep layers of biofilms grow at 
a slower rate because of insufficiency of oxygen and nutrients compared to those 
located on the surface, and they become insensitive to antibiotics due to their reduced 
metabolic activities (Richards et al., 2009, Stewart et al., 2001, He et al., 2011). As a 
result of these resistance mechanisms, a much higher dosage of antibiotics is required 
to achieve the same antimicrobial efficacy on biofilm microbes than on planktonic 
ones (Anwar et al., 1990, Costerton et al., 1987, Khoury et al., 1992). 
 
Biofilm-associated infections have become one of the most devastating medical 
complications. For instance, the US Centers for Disease Control and Prevention 
estimated that healthcare-associated infections were among the top ten leading causes 
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of death in the United States, accounting for 1.7 million infections and 99,000 
associated deaths (Klevens et al., 2007). Many antibiotics including penicillin, 
methicillin and sulfonamides have been used in the treatment of bacterial infections. 
However, the widespread use of antibiotics in the agricultural and biomedical fields 
has been identified as the main cause for the emergence of multidrug-resistant 
microbes.  
 
Clearly, an antimicrobial strategy which is not antibiotic-based would be desirable for 
combating biofilm-associated infections. Lasers have been used for disrupting 
biofilms in recent years (Krespi et al., 2008). For instance, the combination of 
Q-switched Nd-YAGSW (SW) and NIR diode (NIR) lasers can result in a decrease of 
more than 43% of methicillin-resistant Staphylococcus aureus (S. aureus) biofilm 
cells (Krespi et al. 2011). However, the need for specialized equipment such as SW 
and NIR could be a limitation for the widespread use of these radiation-based 
treatment methods. Recently, it was reported that gentian violet (GV) and ferric 
ammonium citrate (FAC) possess biofilm disruption properties. After 24 h of 
continuous exposure to GV (1225 µmol/L), few live Pseudomonas aeruginosa (PA) 
biofilm cells were detected, and FAC at 250 µmol/L significantly decreased the 
fluorescence of otopathogenic Pseudomonas aeruginosa (OPPA8) biofilms after 24 h 
of exposure (p < 0.03) (Eric et al., 2008). In other investigations, MgF2 nanoparticles 
were shown to be capable of penetrating both Escherichia coli (E. coli) and S. aureus 
cells, and could restrict the formation of biofilms (Lellouche et al., 2009). Ag-loaded 
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chitosan nanoparticles also show synergistic antimicrobial effect against S. aureus 
bacteria (Ali et al., 2011). Nevertheless, the use of MgF2 and Ag may not be 
appropriate as they pose possible environmental problems and toxicity to certain 
mammalian cells (Mukherjee et al., 2012, Kim et al., 2011). 
 
In this present study, an antimicrobial and anti-biofilm strategy involving the use of 
carboxymethyl chitosan (CMCS) coated on polydopamine (PDA) pre-treated 
magnetic iron oxide nanoparticles (MNPs) is presented. Chitosan is a cationic 
polysaccharide derived from chitin which is commonly extracted from crustacean 
shells. Its antibacterial properties
 
(Li et al., 2008, Raafat et al., 2008, Lou et al., 2011) 
and biocompatible nature (Ahmadi et al., 2008, Mattanvee et al., 2009) have attracted 
considerable interest in recent years. The carboxymethylation of chitosan increases its 
solubility in water, and promotes the dispersion of CMCS-coated MNPs in aqueous 
media. The increase in –NH3
+ 
groups, resulting from the intra- and intermolecular 
interaction between –COOH and –NH2 groups may also enhance the antibacterial 
properties of CMCS-coated MNPs (Liu et al., 2001). Our results showed that this 
antimicrobial system is highly effective in eliminating planktonic cells of both 
Gram-positive S. aureus and Gram-negative E. coli. The use of a magnetic field in 
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2.1 Biofilm 
A biofilm is a gathering of bacterial cells enclosed in a self-produced polymeric 
matrix composed of extracellular polymeric substances, mainly exopolysaccharides, 
proteins and nucleic acids. Biofilms may form on living or non-living surfaces and 
can be prevalent in natural, industrial and hospital settings (Hall-Stoodley et al., 2004, 
Lear et al., 2012). Biofilm cells often display enhanced tolerance towards antibiotics 
and immune responses and they also exhibit an altered phenotype with respect to 
growth rate and gene transcription, which are very different from the single-cells in a 
liquid medium (Madsen et al., 2012). 
 
2.1.1 Formation and development of biofilm 
Biofilms are present on nearly all types of surfaces, ranging from industrial equipment 
to surgical implants, medical devices as well as living tissues. The formation of a 
biofilm begins with the initial attachment of free-floating microorganisms to surface. 
The first colonists adhere to surface initially through weak, reversible adhesion via 
van der Waals forces. Those cells can anchor themselves more permanently using cell 
adhesion structures such as pili (Karatan et al., 2009), when they are not immediately 
separated from the surface. Once the colonization has begun, the cells in biofilms 
grow through a combination of cell division and recruitment. The formation of a 
biofilm ended with the last step known as development, which may result in an 
aggregate cell colony becoming increasingly antibiotic resistant. Figure 2-1 shows a 
complex developmental process of biofilm maturation involving five stages: stage 1, 
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initial attachment; stage 2, irreversible attachment; stage 3, maturation Ⅰ; stage 4, 
maturation Ⅱ; stage 5, dispersion. Each stage of development in the diagram is paired 
with a photomicrograph of a developing Pseudomonas aeruginosa biofilms. All 
photomicrographs are shown to same scale. 
 
 
Figure 2-1 Biofilm maturation is a complex developmental process involving five stages 
(Monroe, 2007) 
 
2.1.2 The mechanisms of resistance to antibiotics 
Bacteria growing in biofilms are embedded within a self-produced matrix of 
extracelluar polymeric substance (EPS), and thus can be insensitive to antibiotics and 
microbicides that could eliminate them in the plankonic state. In addition, this matrix 
protects the cells within it and facilitates communication among them through 
biochemical signals. Figure 2-2 shows the three main hypotheses for antibiotic 
resistance mechanisms in biofilms.  
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The first hypothesis is the possibility of slow or incomplete penetration of the 
antibiotics into the biofilms. Measurements of antibiotics penetration into biofilms in 
vitro have shown that some antibiotics readily permeate bacterial biofilms (Stewart et 
al., 1996). However, some antibiotics are adsorbed on the biofilm matrix which can 
reduce its penetration into the biofilms. This may account for the slow penetration of 
aminoglycoside antibiotics (Kumon et al., 1994) since these positively charged agents 
bind to the negatively charged polymers in the biofilm matrix. 
 
Secondly, the exchange of genetic materials and the mutation of bacteria in biofilms 
occur more frequently than in planktonic populations. Therefore, development of 
resistance mechanisms can quickly be selected for and propagated throughout the 
community. Some of the bacteria may differentiate into a protected phenotypic state 
and become more resistance to antiobics (Tamilvanan, 2010). 
 
The third mechanism of antibiotic resistance is the altered chemical 
microenvironment within the biofilms. The depletion of a substrate or accumulation 
of an inhibitive waste product may cause some bacteria to enter into a non-growing 
state, in which they become insensitive to antibiotics. De Beer et al. (1994) reported 
that oxygen can be completely consumed in the surface layers of a biofilm, leading to 
anaerobic niches in the deep layers of the biofilms. Aminoglycoside antibiotics, for 
instance, are less effective against the same microorganism in anaerobic than in 
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aerobic conditions (Tack et al., 1985). Local accumulation of acidic waste products 
may lead to pH differences between the biofilm surface and the biofilm interior 
(Vroom et al., 1999), which could directly antagonise the action of an antibiotic. For 
instance, Baudoux et al. (2007) reported that antibacterial activities against 




Figure 2-2 Three hypotheses for mechanisms of antibiotic resistance in biofilms (Stewart et 
al., 2001) 
 
2.1.3 Infectious diseases 
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Biofilms have been found to be involved in a wide variety of microbial infections in 
the body, and they account for nearly 80% of all infections. The US Centers for 
Desease Control and Prevention reported that biofilm-associated infections were 
among the top ten leading causes of death in the United State, accounting for 1.7 
million infections and 99,000 associated deaths (Klevens et al., 2007). There are two 
main aspects of biofilm-associated infections, common problems such as urinary tract 
infections, catheter infections, coating contact lenses, gingivitis, and the less common 
but more lethal processes such as endocarditis, infections in cystic fibrosis and 
infections of permanent indwelling devices such as joint prostheses and heart valves. 
It is apparent that biofilm-associated infections can potentially become one of the 
most devastating medical complications, if new and better approaches for combating 
them are not implemented. 
 
2.1.4 Disruption of biofilm 
Much of work has been done with the purpose of disrupting the biofilms: (1) Laser 
and photodynamic treatment have been used to disrupt bacterial biofilms. Krespi et al 
(2011) reported that the combination of Q-switched Nd-YAGSW (SW) and NIR 
diode (NIR) lasers can result in a decrease of more than 43% of methicillin-resistant S. 
aureus biofilm cells. However, the need for specialized equipment such as SW and 
NIR could be a limitation for the widespread use of these radiation-based treatment 
methods. (2) Gentian violet (GV) and ferric ammonium citrate (FAC) have also been 
reported to possess biofilm disruptive activity. After 24 h of continuous exposure to 
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GV (1225 µmol/L), few live Pseudomonas aeruginosa (PA) biofilm cells were 
detected (Eric et al., 2008). FAC at 200 µM caused disruption of PA biofilms after a 
5-day incubation period (Musk et al., 2005). (3) Lellouche et al. (2009) demonstrated 
that nanosized magnesium fluoride (MgF2) was capable of penetrating E. coli and S. 
aureus cells and inhibiting biofilm formation. (4) Magnetic microspheres coated with 
Ag nanoparticles-loaded multilayers were also shown to possess significant 
bactericidal properties against both Gram-positive Staphylococcus epidermidis and 
Gram-negative E. coli bacteria (Lee et al., 2005). Nevertheless, the use of MgF2 and 
Ag may not be appropriate as they pose possible environmental problems and toxicity 
to certain mammalian cells (Mukherjee et al., 2012, Kim et al., 2011). 
 
In the present work, magnetic iron oxide nanoparticles (MNPs) functionalized with 
bactericidal moieties are used for disruption of biofilms. MNPs are iron oxide 
particles with diameters between about 1 and 100 nm, and they have attracted 
extensive interest in biomedical field due to their superparamagnetic properties, 
biocompatibility and lack of toxicity to humans (Hanini et al., 2011, Markides et al., 
2012). With the use of a magnetic field, the functionalized nanoparticles can then be 
delivered to specific locations where bacteria were present. 
 
2.2 Chitosan 
Chitosan is a cationic polysaccharide derived from chitin, which is commonly 
extracted from crustacean shells such as crabs and shrimp, the cuticles of insects, and 
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the cell walls of fungi. Figure 2-3 shows the structures of chitin and chitosan. Chitin is 
the most abundant natural amino polysaccharide (Majeti N. V. R. K., 2000) and 
represents the major source of nitrogen accessible to countless living terrestrial and 
marine organisms. The antibacterial properties (Li et al., 2008, Raafat et al., 2008, 
Lou et al., 2011) and biocompatible nature (Ahmadi et al., 2008, Mattanavee et al., 
2009) of chitosan have attracted considerable interest in recent years. The 
carboxymethylation of chitosan increases its solubility in water, and the increase in 
−NH3
+ 
groups, resulting from the intra- and intermolecular interaction between 
−COOH and −NH2 groups, may also enhance the antibacterial properties of CMCS 
(Liu et al., 2001). The aim of the present study is to formulate an antimicrobial and 
antibiofilm strategy, and chitosan is considered one of the most promising materials 







































Figure 2-3 Structures of chitin and chitosan (Jayakumar et al., 2010) 
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2.2.1 Physical and chemical characteristics  
Chitosan is a polysaccharide composed of N-glucosamine and N-acetyl-glucosamine 
units, in which the number of N-glucosamine units exceeds 50% (Sodhi Rana et al., 
2001). Chitosan has found several applications due to its excellent chemical, physical, 
and biological properties, such as biocompatibility, biodegradability, nontoxicity, 
adsorptive properties, and most importantly, antimicrobial activity. Some properties of 
chitosan such as the degree of N-deacetylation, molecular weight and solubility can, 
and to a great extent, influence the antibacterial efficacy.  
 
One of the most important parameter to examine closely is the degree of deacetylation 
of chitin. Takahashi et al. (2008) reported that the higher degree of deacetylation, the 
higher antibacterial efficacy of chitosan against S. aureus and E. coli bacteria. In 
addition, the molecular weight of chitosan can also affect the antimicrobial ability 
(Tsai et al., 2006). Viscometry is the simplest and most rapid method for determining 
the molecular weight. The constants а and κ in the Mark-Houwink equation have been 
determined in 0.1 M acetic acid and 0.2 M sodium chloride solution. The intrinsic 
viscosity is expressed as [η] = κMа = 1.81 * 10-3 M0.93, η is the intrinsic viscosity of 
chitosan solution and M is the average molecular weight (Kumar, 2000). Chitosan is a 
polyelectrolyte in acidic media because of the protonation of the amine (-NH2) groups. 
For instance, when chitosan is dispersed in acetic acid solution at different 
concentrations the following equilibria have to be considered:  
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        Chit-NH3
+
 + H2O 
Rinaude et al. (1999) reported that complete solubilization was obtained when the 
degree of protonation exceeded 50% and the ([CH3COOH] / [Chit-NH2]) ratio was 
0.6. Despite chitosan’s desirable solubility in acid media, its actual use is limited by 
the poor solubility in water. A lot of modification techniques and derivatives such as 
O-carboxymethyl chitosan, N-carboxymethyl chitosan and O-succinyl chitosan have 
been developed to improve its solubility. Among the water-soluble chitosan 
derivatives, O-carboxymethyl chitosan (Figure 2-4) is an amphiprotic ether derivative, 
containing –COOH groups and –NH2 groups in the molecule. There are many 
outstanding properties of O-carboxymethyl chitosan such as non-toxicity, 


















Figure 2-4 Schematic diagram illustrating the synthesis of O-carboxymethyl chitosan 
 
2.2.2 Antimicrobial action 
The exact mechanisms of antibacterial activities of chitosan and its derivatives are 
still unknown. It is known that the antimicrobial activity is influenced by a number of 
factors. 
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(a) Chitosan structure 
The polycationic structure of chitosan is a prerequisite for antibacterial activity. When 
the environmental pH is below 6.5 (the pKa value of chitosan), electrostatic 
interaction between the polycationic chitosan and the predominantly anionic 
components of the microbial cell membrane plays a primary role in the antibacterial 
activity. Through this process, chitosan can disrupt the normal functions of the cell 
membrane by promoting cell lysis and by inhibiting nutrients transport (Eldin et al., 
2008, Gu et al., 2007). When the positive charge density of chitosan increases, the 
antibacterial property will increase correspondingly, as is the case with quaternized 
chitosan (Xie et al., 2007). In addition, the number of amino groups linking to C-2 on 
the chitosan backbone also plays an important role in the electrostatic interaction. 
Large numbers of amino groups are able to enhance the antibacterial activity. Another 
but still controversial mechanism is that the positively charged chitosan interacts with 
cellular DNA of some fungi and bacteria, which consequently inhibits the RNA and 
protein synthesis (Meng et al., 2012). In this mechanism, chitosan must be hydrolyzed 
to low molecular weight to penetrate into the cell of microorganisms (Tokura et al., 
2007).  
  
(b) Microorganism structure 
Gram-negative bacteria possess an outer membrane (OM) that contains 
lipopolysaccharide (LPS), which provide the bacteria with a hydrophilic surface 
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(Figure 2-5). The lipid components and the inner core of the LPS molecules contain 
anionic groups (phosphate, carboxyl), which contribute to the stability of the LPS 
layer through electrostatic interactions with divalent cations (Helander et al., 1997). 
Removal of these cations by chelating agents results in destabilization of the OM 
through the release of LPS molecules. The OM serves as a penetration barrier against 
macromolecules and hydrophobic compounds, and thus Gram-negative bacteria are 
relatively resistant to hydrophobic antibiotics and toxic drugs. Therefore, overcoming 
the outer membrane is a prerequisite for any material to exert bactericidal activity 
towards Gram-negative bacteria (Kong et al., 2008a). 
 
 
Figure 2-5 Schematic view of the Gram-negative cell envelope (Helander et al., 1997) 
 
The cell wall of Gram-positive bacteria comprises peptidoglycan (PG) and teichoic 
acid (TA) (Figure 2-6). TA is an essential polyanionic polymer of the cell wall of 
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Gram-positive bacteria, which traverses the wall to contact with the PG layer. They 
can be either anchored into the outer leaflet of the cytoplasmic membrane via a 
glycolipid (lipoteichoic acids, LTA) or covalently linked to N-acetylmuramic acid of 
the PG layer (Raafat et al., 2008). Poly (glycerol phosphate) anion groups make TA 
responsible for structural stability of the cell wall. Besides, it is crucial for the 
function of various membrane-bound enzymes. Comparatively, TA's counterpart, LPS 
in the cell wall of Gram-negative bacteria, acts in a similar fashion.  
 
 
Figure 2-6 Gram-positive cell walls (Cabeen et al., 2005) 
 
Despite the distinction between Gram-negative and Gram-positive bacterial cell walls, 
antibacterial modes both begin with the interactions at the cell surface which 
compromise the OM or cell wall. The LPS and proteins in the Gram-negative bacteria 
OM are held together by electrostatic interactions with divalent cations that are 
required to stabilize the OM. Polycations may compete with divalent metals for 
binding with polyanions when the pH is below pKa of chitosan and its derivatives. 
However, chelation occurs when pH is above the pKa. Replacement of divalent 
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metals present in the cell wall will likely disrupt the integrity of the cell wall or 
inﬂuence the activity of degradative enzymes. For Gram-positive bacteria, LTA could 
provide a molecular linkage for chitosan at the cell surface, allowing it to disturb 
membrane functions (Raafat et al., 2008). Once the cells lose the protection of the cell 
wall, the cell membrane is exposed to the external influence. The functions of cell 
membrane can be changed consequently, with alteration in the membrane 
permeability (Kong et al., 2008a). 
 
2.2.3 Applications of chitosan 
(a) Food preservation 
Chitosan has been approved as a food additive in Korea and Japan since 1995 and 
1983, respectively (KFDA, 1995, Weiner, 1992). Due to its ability of forming 
semi-permeable film, chitosan coating can be expected to modify the environment of 
packaged food, to decrease the transpiration loss (Elghaouth et al., 1991) and to delay 
the ripening of fruits (Elghaouth et al., 1992). As a component of packaging material, 
chitosan not only retards microorganism growth in food, it also improves the quality 
and shelf life of food. Various kinds of chitosan-based packaging films modified with 
new polymeric material such as chitosan/polyethylene oxide film (Maher et al., 2008) 
and chitosan-nylon-6/Ag blended membranes (Ma et al., 2008) have been developed. 
Instead of polyethylene or polypropylene petrochemical materials which are inedible 
or not made from renewable natural resources, these new materials are 
environmentally-friendly and biodegradable. 
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(b) Medical industry 
Chitosan has been used in the area of health care and hygienic applications because it 
is a natural, biocompatible, anti-infective mucoadhesive, and hemostatic polymer, 
which may be incorporated into fibers, membrane, or hydrogel, and used for wound 
dressing, drug delivery carrier and orthopaedic tissue engineering. An ideal wound 
dressing material must be capable of absorbing the exuded liquid from the wounded 
area and should permit water evaporation at a certain rate and allow no microbial 
transport (Yang et al., 2004). Chitosan immobilized on poly(N-isopropylacrylamide) 
(PNIPAAm) gel/polypropylene (PP) nowoven composites surface have 
hydrogel-forming properties and are considered to be advantageous in their 
application as a wound dressing material (Chen et al., 2005). Surgical and 
pharmaceutical materials introduced into human body for tissue engineering or as 
drug release systems, for instance, suffer from potential complications arising from 
microorganism infections. It is apparent that once the introduced materials are 
infected, high morbidity and mortality rate can be expected. Therefore, efforts have 
focused on the development of bacterial-resistant prosthetic parts through binding of 
antimicrobial polymers to the materials. For instance, chitosan hydrogel coated grafts, 
crosslinked upon ultraviolet light irradiation, exhibited a resistance against E. coli in 
vitro and in vivo (Fujita et al., 2004). Silicone is widely used for implantable 
biomedical devices such as catheters (Stevens et al., 2009) and stents (Venkatesan et 
al., 2010). Wang et al. (2012) reported that O-carboxymethyl chitosan coated silicone 
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surface can inhibit the formation of E. coli and Proteus mirabilis (P. mirabilis) 
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3.1 Materials  
Polystyrene (PS) sheets of 1.2 mm thickness were purchased from Goodfellow. Ferric 
chloride hexahydrate (FeCl3·6H2O, > 99%), ferrous chloride tetrahydrate 
(FeCl2·4H2O, > 99%), dopamine hydrochloride (> 99%), monochloroacetic acid (> 
99%), rhodamine isothiocyanate (RITC), dimethyl sulfoxide (DMSO), 
3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and folate-free 
Dulbecco’s modified Eagle’s medium (DMEM) were obtained from Sigma-Aldrich 
(St. Louis, MO). Chitosan was purchased from CarboMer Inc. and used as received. 
Ultra-pure water (> 18.2 MΩ cm, Millipore Milli-Q system) was used in the 
experiments. S. aureus 25923, E. coli DH5α and 3T3 fibroblasts were obtained from 
American Type Culture Collection (ATCC). Sodium hydroxide (NaOH), potassium 
bromide (KBr), isopropanol, ethanol and acetone were all analytical reagent (AR) 
grade and obtained from Sigma-Aldrich or Merck Chem. Co.. 
 
3.2 Synthesis of Carboxymethyl Chitosan (CMCS) 
Carboxymethyl chitosan (CMCS) was prepared according to a method described by 
Chen et al. (2003). 3.00 g of purified chitosan was added to 40% (w/w) aqueous 
NaOH and kept at 0°C overnight for alkalization. The cold alkali solution was put into 
a 250 mL reactor containing 60 mL isopropanol, and then 9.00 g of monochloroacetic 
acid in isopropanol (3 mL) was slowly added to the mixture over a 30 min period. 
After reaction for 12 h at room temperature, 200 mL of 70% (v/v) ethanol was added 
to stop the reaction. Finally, the solid was filtered, washed with ethanol and dried in a 
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vacuum oven at 60°C for 24 h. The products were dissolved in dilute ammonia (0.1 
g/mL) and centrifuged to remove the unreacted chitosan. The CMCS was precipitated 
by ethanol from the water-soluble portion, filtered and dried under reduced pressure at 
60°C for 24 h. 
 
3.3 Synthesis of Magnetic Iron Oxide Nanoparticles (MNPs) 
The MNPs were prepared using a controlled coprecipitation method following the 
reported procedure (Mikhaylova et al., 2004). In brief, FeCl3·6H2O (6.75g, 25 mmol), 
FeCl2·4H2O (2.48g, 12.5 mmol) and 1 mL 37% (v/v) HCl were dissolved in 24 mL 
ultra-pure water under vigorous stirring. The coprecipitation of MNPs was achieved 
by adding the iron solution to 250 mL of 0.5 M NaOH (under stirring at 1000 rpm), 
which was preheated to 80°C. The reaction was carried out for 1 h under the 
protection of nitrogen. The particles were then collected by sedimentation with a help 
of an external magnet and washed several times with ultra-pure water until a stable 
ferrofluid was obtained. The solid MNPs were freeze-dried and stored under nitrogen 
prior to further modification and characterization.  
 
3.4 Synthesis of Magnetic Carboxymethyl Chitosan Nanoparticles 
(CMCS-MNPs)  
The CMCS-MNPs were synthesized as reported by Lee et al. (2007) with some minor 
modifications. 30 mg of MNPs and 45 mg of dopamine hydrochloride were added 
into 30 mL of 10 mM Tris-Cl solution (pH = 8.5) and dispersed by sonication for 1 h 
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in an ice bath (Young et al., 2009). The reaction mixture was stirred at room 
temperature for 3 h to obtain the polydopamine coated magnetic nanoparticles 
(PDA-MNPs). The PDA-MNPs were collected under a magnetic field, washed three 
times with ultra-pure water to remove any loosely adsorbed PDA , and then dispersed 
in 20 mL phosphate buffered saline (PBS (10 mM, pH = 7.4)). After that, 20 mL of 
CMCS solution (10 mg/mL in PBS) was added, and the reaction mixture was 
incubated overnight in an orbital shaker at 180 rpm. The CMCS-MNPs were collected 
by centrifugation, and washed three times with ethanol and water to remove the 
excess CMCS. For the preparation of fluorescent RITC-CMCS-MNPs (Bhattacharya 
et al., 2011), 10 mg CMCS-MNPs was dispersed in 30 mL PBS, and 1 mL of RITC 
solution (1 mg/mL in DMSO/H2O (1/1, v/v)) was then added dropwise to the mixture. 
The reaction mixture was ultrasonicated in the dark for 1 h. The nanoparticles were 












Figure 3-1 Schematic illustration for the preparation of CMCS-MNPs and 
RITC-CMCS-MNPs 
 
3.5 Determination of Antibacterial Efficacy against Planktonic Cells  
S. aureus and E. coli were cultured in tryptic soy broth and nutrient broth, respectively, 
overnight at 37°C. The bacterial suspensions were centrifuged at 2700 rpm for 10 min. 
After removal of the supernatant, the cells were washed twice with sterile PBS and 
then resuspended in PBS to reach a concentration of 10
6
 cells/mL. All lab wares were 
sterilized under UV irradiation for 1 h before the experiments. 
 
Five mL of the bacterial-containing PBS suspension was mixed with 5 mL 
CMCS-MNPs (4.0 mg/mL) or 5 mL CMCS solution (0.68 mg/mL, to maintain the 
same concentration of CMCS as that in CMCS-MNPs which contained ~ 17% CMCS 
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as determined by thermogravimetric analysis (TGA)). The final concentration of 
CMCS-MNPs and CMCS in the bacteria-containing PBS suspension was 2.0 mg/mL 
and 0.34 mg/mL, respectively. Control experiments were carried out with PBS 
solution without CMCS-MNPs or CMCS. The suspensions were then placed in sterile 
tubes in an orbital shaker maintained at 37°C and 200 rpm (Figure 3-1). The number 
of viable bacteria at 2, 4, 6, 8 and 10 h for S. aureus and at 1, 2, 3, 4 and 5 h for E. coli 








Figure 3-2 Schematic representation of antibacterial assay using CMCS-MNPs against 
planktonic cells 
 
3.6 Determination of Biofilm Disruption Efficacy  
PS sheets were cut into 1 × 1 cm
2
 pieces, washed ultrasonically in acetone and ethanol, 
for 10 min in each step, and then rinsed with copious ultra-pure water after each wash. 
After that, the substrates were immersed in ultra-pure water for 10 min, and then 
blown dry under a flow of purified N2. The PS substrates were sterilized with UV 
CMCS-MNPs added 





Chapter 3                                                            Experimental 
 
27 
irradiation for 1 h before use. 
 
Bacterial broth suspension (1 mL) at a concentration of 10
6
 cells/mL was added to 
each 24-well plate with PS substrates (for scanning electron microscopy (SEM) and 
confocal laser scanning microscopy (CLSM) observation) or without PS substrates 
(for viable bacterial cell count). The biofilms were allowed to grow at 37°C for 48 h, 
with the culture broth replenished after 24 h. For the viable bacterial cell count 
experiment, 1 mL of CMCS-MNPs (1.0 or 2.0 mg/mL) or CMCS (0.34 mg/mL) in 
PBS solution was added to each well with pre-grown biofilms. A magnet (39.5 mm × 
24.5 mm × 5.0 mm, field strength 355 ± 30 G) was placed under the 24-well plate and 
the magnetic field was maintained for 5 min before the suspension was removed 
(Figure 3-2). The 5 min exposure time to CMCS-MNPs was chosen because it was 
found that ~ 95% of these nanoparticles would settle to the bottom of the well within 
5 min under the magnetic field (as determined by UV-visible absorption). The wells 
were then refilled with 1 mL sterile PBS (10 mM, pH = 7.4), and the bacteria were 
allowed to incubate at 37°C for 12, 24 and 48 h. Control experiments were carried out 
with the pre-grown biofilms in sterile 1 mL PBS (10 mM, pH = 7.4) without any 
CMCS-MNPs or CMCS. For the SEM observation, the PS substrates were removed 
from the wells with sterile forceps, washed three times with sterile PBS (10 mM, pH= 
7.4), fixed in 3% (v/v) glutaraldehyde in PBS solution for 30 min at room temperature, 
and immersed in 25%, 75%, 100% ethanol stepwise for dehydration. The PS 
substrates were dried, coated with platinum, and observed under SEM (JEOL, model 
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5600LV, Tokyo, Japan). For the CLSM observation, the CMCS-MNPs-treated 
biofilms were stained with LIVE/DEAD Baclight viability kit (Molecular Probes Inc, 
L1352). In addition, the biofilms treated with fluorescent RITC-CMCS-MNPs were 
only stained with SYTO9 dye from the kit to differentiate between the live bacteria 
(green fluorescence) and the nanoparticles (red fluorescence). After 20 min incubation 
in the dark, images were taken using a Nikon Ti-E microscope with A1 confocal 
system (Nikon, Tokyo, Japan). A Multi-Argon 488 nm laser was used as the source of 
illumination, with 488 nm excitation, long-pass 500-530 nm emission filter settings 
for the green signal and 570-620 nm emission filter settings for the red signal. 











Figure 3-3 Schematic representation of antibacterial assay using CMCS-MNPs against 
biofilm 
CMCS-MNPs 
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3.7 Bacterial Quantification 
For quantification of the viable bacterial cells in the biofilms, the 24-well plate after 
the pre-determined incubation period (12, 24, and 48 h) was subjected to 
ultrasonication for 10 min in a 100 W ultrasonic bath operating at a nominal 
frequency of 50 Hz. The bacteria-containing suspensions were transferred into 15 mL 
centrifuge tubes and subjected to rapid vortex mixing for 20 s. Serial ten-fold 
dilutions were performed and the number of bacteria cells was counted using the 
spread plate method. For the planktonic cells experiments, 0.1 mL of the bacterial 
suspension after the specified incubation period was pipetted out and added into 0.9 
mL sterile PBS (10 mM, pH = 7.4). Serial ten-fold dilutions were performed and the 
number of bacteria cells was counted using the spread plate method. All experiments 
were performed in quintuplicate with five substrates and the mean values were 
calculated. 
 
3.8 Cytotoxicity of Nanoparticles 
3T3 fibroblast cells were cultured in DMEM supplemented with 10% fetal bovine 
serum, 100 IU/mL penicillin, and 1 mM L-glutamine. The cells were seeded at a 
density of 10
4
 cells per well and incubated for 24 h at 37°C before the medium was 
replaced with fresh one containing CMCS and CMCS-MNPs at a concentration of 
0.34 mg/mL and 2.0 mg/mL, respectively. The runs with CMCS-MNPs were carried 
out with and without a magnet placed at the bottom of the well. Control experiments 
were carried out using the complete growth culture medium without CMCS or 
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CMCS-MNPs. The cells were incubated at 37°C for another 24 h in the medium. The 
culture medium from each well was then removed and 0.9 mL of medium and 0.1 mL 
of MTT solution (5 mg/mL in PBS) were added to each well. After 4 h of incubation 
at 37°C, the medium was removed and the formazan crystals were solubilized with 1 
mL DMSO for 15 min. The optical absorbance was then measured at 570 nm on a 
microplate reader (Tecan GENios). The results were expressed as percentages relative 
to the results obtained from the control experiments. 
 
3.9 Characterization  
The hydrodynamic size of the nanoparticles was determined using dynamic light 
scattering (DLS) with a Brookhaven LLS 90 Plus Particle Size Analyzer. To test the 
stability of the CMCS-MNPs in aqueous medium, 10 mg CMCS-MNPs were 
dispersed in 30 mL PBS (10 mM, pH= 7.4) and stored at 4°C in a refrigerator. After 
pre-determined periods of time, 1 ml of the suspension was pipetted out and 
ultrasonicated for 5 min followed by the determination of the hydrodynamic size. The 
zeta potential of the nanoparticles in PBS and bacterial suspension in PBS (10
6
 
cells/mL) were measured using a Zetasizer Nano-ZS analyzer (Malvern Instruments). 
Thermogravimetric analysis was carried out with a TGA 2050 analyzer (TA 
Instruments). The samples were heated from room temperature to 800°C at a heating 
rate of 10 °C/min in air. Fourier transform infrared (FT-IR) spectra of samples 
dispersed in KBr pellets were obtained in the transmission mode on a Bio-Rad FT-IR 
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4.1 Characterization of CMCS-MNPs 
Figure 4-1 shows the FT-IR spectra of MNPs, PDA-MNPs, and CMCS-MNPs, 
respectively. Comparing the FT-IR spectrum of MNPs (Figure 4-1a) and PDA-MNPs 
(Figure 4-1b), an absorption band at 1503 cm
-1 
can be observed in the latter. This band 
is the characteristic absorption band of aromatic rings of PDA (Zhu et al., 2011), 
indicating the successful coating of PDA on the surface of MNPs. After the 
conjugation with CMCS, the spectrum of CMCS-MNPs (Figure 4-1c) showed not 
only the main absorption peak of naked Fe3O4 nanoparticles at 590 cm
-1
 (Figure 4-1a) 
but also the characteristic peaks of CMCS at 1596 cm
-1
 and 1422 cm
-1
, which are 
assigned to the respective asymmetry and symmetry stretch vibration of the COO
-
 
groups (Liang et al., 2007). The large difference between the zeta potential of 
PDA-MNPs (41.6 ± 9.1 mV) and CMCS-MNPs (-40.4 ± 5.8 mV) also indicates that 
CMCS has been successfully coated on the PDA-MNPs (Table 4-1). The positive zeta 
potential of PDA-MNPs is due to the amine groups in PDA (Gomes et al., 2009, 
Aviles et al., 2010),
 
while the negative zeta potential of CMCS-MNPs can be 
attributed to –COOH groups in CMCS (Shi et al., 2009). Despite the fact that 
CMCS-MNPs are highly negatively-charged, by using these nanoparticles with a 
magnetic field, the nanoparticles can effectively penetrate into and disrupt bacterial 
biofilms (see Section 4.3). The hydrodynamic size of PDA-MNPs and CMCS-MNPs 
are 105.2 ± 1.1 nm and 268.9 ± 5.3 nm, respectively. The increase in the 
hydrodynamic diameter of CMCS-MNPs further confirms the presence of the CMCS 
layer on the surface of PDA-MNPs.  
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PDA- MNPs 41.6 ± 9.1 105.2 ± 1.1 
CMCS-MNPs -40.4 ± 5.8 268.9 ± 5.3 
 
























Figure 4-1 FT-IR spectra of (a) MNPs, (b) PDA-MNPs and (c) CMCS-MNPs 
 
Figure 4-2 shows the respective TGA plot of MNPs, PDA-MNPs and CMCS-MNPs 
in an air atmosphere. The PDA and CMCS layers accounted for 28% and 17% of the 
weight of the CMCS-MNPs, respectively. The PDA and CMCS confer a high level of 
dispersibility to the nanoparticles in aqueous media, and Figure 4-3 shows that the 
hydrodynamic size of CMCS-MNPs did not change significantly during one month in 
PBS. 























Figure 4-2 TGA curves of (a) MNPs, (b) PDA-MNPs and (c) CMCS-MNPs 



























Figure 4-3 Hydrodynamic size of CMCS-MNPs after incubation in PBS for different periods. 
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4.2 Antibacterial Efficacy against Planktonic Cells  
The number of viable S. aureus and E. coli cells as a function of time after the 
addition of CMCS and CMCS-MNPs to the bacterial suspension (10
6
 cells/mL in PBS) 
was investigated by the spread plate method. The antibacterial activity of CMCS and 
CMCS-MNPs are compared in Figure 4-4. As shown in Figure 4-4a, the number of S. 
aureus viable cells in the suspension decreased by 26% and 30% after 2 h in contact 
with CMCS and CMCS-MNPs, respectively, whereas the viable cell number did not 
change significantly in the absence of CMCS and CMCS-MNPs (control). The 
number of viable cells progressively decreased in the presence of CMCS and 
CMCS-MNPs, and more than 99% cells were killed after 10 h in these suspensions. 
For E. coli (Figure 4-4b), the reduction in viable cells progressed more rapidly, and 
the number of viable cells decreased more than 50% and 54% after 2 h in contact with 
CMCS and CMCS-MNPs, respectively, and in 5 h, almost all bacterial cells have been 
killed. Eric et al. (2008) had suggested that iron in FAC is capable of killing bacteria, 
but we found that when the antibacterial assays were carried out with MNPs and 
PDA-MNPs, no significant antibacterial properties against both S. aureus and E. coli 
bacteria was observed (p > 0.05 compared to control, Figure 4-5). The difference in 
antibacterial action of FAC and MNPs may be attributed to the presence of free iron 












































































Figure 4-4 Antibacterial effect of CMCS-MNPs (2.0 mg/mL) and CMCS (0.34 mg/mL) on (a) 
S. aureus and (b) E. coli suspensions (10
6
 cells/mL). The controls refer to the bacterial 
suspensions without CMCS or CMCS-MNPs. 
b 
a 
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Figure 4-5 Antibacterial effect of MNPs (2.0 mg/ml) and PDA-MNPs (2.0 mg/ml) on (a) S. 
aureus and (b) E. coli suspensions (10
6
 cells/mL). The controls refer to the bacterial 
suspensions without MNPs or PDA-MNPs.
a 
b 
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The observed bactericidal action in Figure 4-4 is attributed to the effect of CMCS, 
which can bind to bacterial cell surface via electrostatic interaction of its positively 
charged amino groups with the negatively charged cell membrane (Raafat et al., 2008). 
Through this process, CMCS can disrupt the normal functions of the membrane by 
promoting cell lysis and by inhibiting nutrients transport (Eldin et al., 2008, Gu et al., 
2007, Du et al., 2009). Figure 4-4 also shows that S. aureus have a comparatively 
greater resistance to CMCS than E. coli. This may be explained by the differences in 
cell wall structure and composition between those two types of bacteria. In addition, 
zeta potential measurements of bacterial suspensions (10
6
 cells/mL in PBS (10 mM, 
pH = 7.4)) indicate that the negative charge on the cell surface of E. coli (zeta 
potential of -32.3 ± 1.1) is higher than on S. aureus (zeta potential of -22.5 ± 3.8), and 
thus the interaction of CMCS with E. coli is probably stronger than with S. aureus. 
 
4.3 Biofilms Disruption  
The results in the preceding section showed that CMCS and CMCS-MNPs can 
effectively eliminate both S. aureus and E. coli bacteria in suspension. However, 
antibacterial assays against planktonic bacteria may not give a representative 
indication of the efficacy against bacteria in biofilms since the dense and protected 
environment of the biofilms may shield the bacteria from antimicrobial agents. Thus, 
the antibacterial properties of CMCS-MNPs on S. aureus and E. coli biofilms were 
also investigated. Figure 4-6 shows the viable cell count in S. aureus and E. coli 
biofilms after treatment with CMCS and CMCS-MNPs for only 5 min. As shown in 
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Figure 4-6a, in the control experiment (pre-grown biofilms in sterile PBS without 
addition of CMCS or CMCS-MNPs), there is a decrease in the number of viable cells 
in the S. aureus biofilm throughout the 48 h incubation period. This finding was 
consistent with the previous study by Fujimoto et al. (2006) that S. aureus required 
many macronutrients and micronutrients to grow. Due to a lack of such nutrients in 
PBS used in the experiments, the S. aureus cells in the biofilm gradually died during 
the incubation period. The S. aureus biofilms treated with CMCS (0.34 mg/mL) and 
CMCS-MNPs (1.0 mg/mL and 2.0 mg/mL) in the absence of MF did not exhibit 
significant differences in viable bacterial cell count as compared to the control (p > 
0.05), throughout the 48 h incubation period. This result illustrates the difficulty for 
antibacterial agents to penetrate the biofilm. However, there was a clear decrease in 
viable bacterial cells within the biofilms when a MF was applied below the 
biofilm-containing wells in the presence of CMCS-MNPs. The difference in the 
results obtained in the absence and presence of MF indicates that penetration of the 
CMCS-MNPs into the biofilms is essential for biofilm disruption. This can be 
confirmed by the use of red fluorescent RITC-CMCS-MNPs to study the penetration 
of nanoparticles into the biofilms in the presence of MF. Figure 4-7 shows the CLSM 
images of S. aureus biofilms (with viable bacterial cells stained green, 
RITC-CMCS-MNPs stained red, and the yellow signal is a combination of the green 
and red signals) treated with RITC-CMCS-MNPs for 5 min with or without a MF. In 
the absence of MF, a few nanoparticles have settled on the biofilms (Figure 4-7a and 
4-7b) within the 5 min exposure period. However, in the presence of MF, the strong 
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yellow signal throughout the biofilms confirms that the RITC-CMCS-MNPs rapidly 
deposited on and penetrated into the biofilms (Figure 4-7c and 4-7d) within 5 min. It 
can also be observed from Figure 4-6a that a higher concentration of CMCS-MNPs 
generally resulted in greater disruption of the biofilms. For instance, after 24 h 
incubation in PBS, the number of viable cells in the biofilm treated with 1.0 mg/mL 
CMCS-MNPs under MF decreased by 54% compared to the control experiment, 
while the corresponding value when 2.0 mg/mL CMCS-MNPs were used in the 
presence of MF was 79%.  
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Figure 4-6 Effect of CMCS-MNPs (with or without MF) and CMCS on pre-grown (a) S. 
aureus biofilms and (b) E. coli biofilms after 12, 24, and 48 h. The controls refer to the 
respective pre-grown biofilms in sterile PBS without addition of CMCS or CMCS-MNPs. 
b 
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The prefix 1.0 and 2.0 represent 1.0 mg/mL and 2.0 mg/mL CMCS-MNPs suspension 
respectively; and the suffix (MF) indicates the application of magnetic field in the 5 min 
period when the biofilms were exposed to the CMCS-MNPs suspension. * denotes significant 
differences (p < 0.05) compared to the control experiment at the same incubation time. 
 
Figure 4-7 CLSM (a,c) volume view and (b,d) cross-sectional view images of S. aureus 
biofilms exposed to RITC-CMCS-MNPs (2.0 mg/mL) (a,b) without a MF and (c,d) with a 
MF. Scale bar = 100 µm. Viable bacterial cells are stained green, RITC-CMCS-MNPs are 
stained red, and the yellow signal arises from a combination of the green and red signals. 
 
The effect of CMCS and CMCS-MNPs on E. coli biofilms in the absence or presence 
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coli biofilms in the control experiment did not exhibit a reduction in viable cell 
number. Young et al. (1997) had reported that growth of E. coli cells was observed 
even after 6 months in intraluminal saline. Similar to the results shown in Figure 6a, 
CMCS and CMCS-MNPs in the absence of MF are not effective in disrupting the 
biofilm over 48 h. However, when the E. coli biofilms were treated with 1.0 mg/mL 
and 2.0 mg/mL CMCS-MNPs in the presence of MF, the viable cell count decreased 
by nearly 60% and 83% after 12 h compared to the control experiment. Furthermore, 
the number of viable cells in the biofilms decreased significantly with time and more 
than 85% and 95% of the cells in biofilms treated with 1.0 mg/mL and 2.0 mg/mL 
CMCS-MNPs under MF, respectively, were killed after 48 h. 
 
CLSM and SEM were used to provide a more illustrative description of the biofilm 
disruption capabilities of CMCS-MNPs under MF. Figure 4-8 shows the CLSM 
images (volume view) of S. aureus and E. coli biofilms (with viable cells stained 
green) after exposure to CMCS-MNPs with or without a MF, following by incubation 
for 24 h in PBS. As can be seen from Figure 4-8a and 4-8d, S. aureus produced 
thicker and denser biofilms than E. coli. This finding is consistent with the SEM 
images in Figure 4-9a and 4-9d. After 24 h, a large portion of the original S. aureus 
and E. coli biofilms treated with 2.0 mg/mL CMCS-MNPs with MF have been 
disrupted (Figure 4-8c and 4-8f, Figure 4-9c and 4-9f). It can be observed from Figure 
4-9c and 4-9f that there is a substantial amount of debris on the PS substrate. This 
debris is attributed to a mixture of the CMCS-MNPs, cell and biofilm fragments, and 
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it can be removed by using a magnet during the rinsing process (data not shown). The 
reduction in the biofilm mass after treatment with CMCS-MNPs in the absence of MF 
(Figure 4-8b and 4-8e, Figure 4-9b and 4-9e) is very much less than that with MF, 
consistent with the quantitative viable bacterial cell count results in Figure 4-6. The 
results in Figure 4-8 and 4-9 clearly indicate that application of CMCS-MNPs with a 
MF is effective in disrupting the biofilms although the percentage decrease in 
bacterial cell count is not as high as that observed in the planktonic cells experiments 
(Figure 4-4). In the experiments with planktonic cells, the direct contact between the 
nanoparticles and the bacterial cells was enhanced by the continuous agitation 
provided by the orbital shaker, and enhanced contact would facilitate the 
membrane-disruptive effect of the CMCS-MNPs. On the other hand, in the biofilms 
experiments, the nanoparticles were basically effective against the bacterial cells in 
their immediate vicinity. A number of bacterial cells may not be in contact with the 
nanoparticles despite the application of MF, and a higher nanoparticle concentration 
will increase the probability of contact. In addition, bacteria in biofilms are more 
resistant to antimicrobial agents than their planktonic counterparts as mentioned 
above, possibly due to different growth characteristics (Dusane et al., 2008) and 
alterations in the membrane protein composition of the biofilm cells (Otto et al., 
2001). 
Chapter 4                                                   Results and Discussions 
 
45 
Figure 4-8 CLSM volume view images of (a-c) E. coli biofilms and (d-f) S. aureus biofilms: (a) 
and (d) pre-grown biofilms after incubation in PBS for 24 h, (b) and (e) with addition of 
CMCS-MNPs (2.0 mg/mL) without MF for 5 min and after incubation in PBS for 24 h, (c) 
and (f) with addition of CMCS-MNPs (2.0 mg/mL) with MF for 5 min and after incubation 
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Figure 4-9 SEM images of (a-c) E. coli biofilms and (d-f) S. aureus biofilms: (a) and (d) 
pre-grown biofilms after incubation in PBS for 24 h, (b) and (e) with addition of 
CMCS-MNPs (2.0 mg/mL) without a MF for 5 min and after incubation in PBS for 24 h, (c) 
and (f) with addition of CMCS-MNPs (2.0 mg/mL) with MF for 5 min and after incubation 
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4.4 Cytotoxicity of Nanoparticles  
While the above results have clearly illustrated the antibacterial efficacy of the 
CMCS-MNPs, its potential cytotoxic effects on mammalian cells must be considered. 
The MTT assay results after incubation of 3T3 fibroblast cells with MNPs (2.0 
mg/ml), CMCS (0.34 mg/mL) and CMCS-MNPs (2.0 mg/mL, with and without MF) 
for 24 h are shown in Figure 4-9. The viability of the fibroblasts in the presence of 
MNPs, CMCS and CMCS-MNPs remained high (96 – 98% as compared to the 
control) regardless of the presence of MF. The lack of cytotoxicity of the CMCS and 
CMCS-MNPs are as expected since Jaiswal et al. (2012) had reported that more than 
95% of both U-87 MG (human glioblastoma astrocytoma) and HT29 (human colon 
adenocarcinoma) cells were viable after 24 h treatment with folic acid conjugated 
chitosan nanocarriers over a wide range of concentration from 0 to 30 µg/mL. 
Another investigation showed that polyethylene glycol (PEG) coated MNPs were 
nontoxic to infinity telomerase-immortalized primary human fibroblasts (Gupta et al., 
2004).
 
In addition, Milovic et al. (2005) had reported that polycationic 
polyethylenimine immobilized on a glass slide can effectively kill E. coli cells by a 
similar membrane-rupturing mechanism as exhibited by chitosan without adverse 
effects on mammalian cells. Though mammalian cell membranes are also negatively 
charged (Mishra et al., 2009), contact with CMCS did not result in the 
membrane-disruptive action observed with bacteria. This phenomenon may be 
attributed to the differences in size and membrane composition between mammalian 
cells and bacterial cells. It was found that the presence of cholesterols (not found in 
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bacterial cell membranes) in mammalian cell membranes inhibited the 
membrane-rupturing ability of the cationic antimicrobial pardaxin, though the 
inhibition mechanism was not well understood (Hallock et al., 2002). Therefore, it 
was possible that the same mechanism also applied when mammalian cells were 






















































Figure 4-10 Viability of 3T3 fibroblast cells incubated for 24 h in growth medium containing 
MNPs (2.0 mg/ml), CMCS (0.34 mg/ml) and CMCS-MNPs (2.0 mg/ml) relative to the control 
(i. e. no CMCS or CMCS-MNPs added). The suffix (MF) indicates the application of 
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Bacteria in biofilms develop resistance to antibiotics via a combination of 
mechanisms. In the present work, a non-antibiotic-based strategy of using 
CMCS-MNPs under an external magnetic field was shown to exhibit strong 
bactericidal activities against biofilms. These nanoparticles are produced from readily 
available chemicals and the process is easily scalable. The bactericidal effects arise 
from the CMCS component on the surface of CMCS-MNPs, while the MNPs acting 
in conjunction with the magnetic field facilitate the penetration of the bactericidal 
agent deep into the biofilms. The antibacterial efficiency is dependent on the 
concentration of CMCS-MNPs and the incubation time. The number of viable cells in 
S. aureus and E. coli biofilms after exposure to 2.0 mg/mL CMCS-MNPs under a 
magnetic field decreased by 84% and 95%, respectively, after 48 h. In addition, 
CMCS-MNPs are also highly effective against planktonic S. aureus and E. coli cells, 
and more than 99% of the cells in contact with these nanoparticles are killed after 10 h 
and 5 h, respectively. CMCS-MNPs are not cytotoxic to mammalian cells, and can 
potentially be used as an antimicrobial agent in a wide range of applications including 
targeting biofilms associated with industrial equipment, biomedical devices or in food 
processing. 




A number of possible methods which may enhance the dispersion and the antibacterial 
efficacy of the functional magnetic nanoparticles can be foreseen. Two examples 
which need further study are given blow: 
 
Enhance the dispersion of the functional MNPs 
In this thesis, the carboxymethylation of chitosan has increased its solubility in water, 
and promoted the dispersion of CMCS-MNPs in aqueous media. Recent studies have 
showed that the chitosan functionalized by other groups such as succinyl and 
dicarboxymethyl possessed a better solubility in water (Jayakumar et al., 2010). It can 
be expected that the dispersion of functional MNPs may be further enhanced by using 
these functional groups in chitosan. 
  
Enhance the antibacterial efficacy of the functional MNPs 
Through the electrostatic interaction of the positively charged amino groups in 
chitosan with the negatively charged cell membrane, chitosan can disrupt the normal 
functions of bacterial membrane by promoting cell lysis and by inhibiting nutrients 
transport. Electrostatic interaction plays an important role in the antibacterial process. 
The results in Section 4.3 showed that despite exposure to CMCS-MNPs under MF, a 
number of bacterial cells in biofilms remained unaffected by the magnetic 
nanoparticles. This may due to the poor attachment between cell membrane and 
magnetic nanoparticles. Some carbohydrates such as glucose, mannose has been 
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reported to attach well to the bacterial membrane (Ip et al., 2009, Eboigbodin et al., 
2007). The carbohydrates and chitosan can be co-immobilized on magnetic 
nanoparticles using click chemistry. Alternatively, using the carbohydrates modified 
chitosan coating on magnetic nanoparticles is another way to achieve the 
multi-functional magnetic nanoparticles. It can be expected that such coatings may 
significantly promote the attachment of the nanoparticles to the cell surface and 
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